{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:35:36Z","timestamp":1784291736114,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.humpath.2026.106057","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:10:23Z","timestamp":1769184623000},"page":"106057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Acute leukemia with BCL11B rearrangements: Genetic landscape, BCL11B expression, and therapeutic response"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-4806","authenticated-orcid":false,"given":"Guilin","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Ying","family":"Jen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias Joseph","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying S.","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.humpath.2026.106057_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/ni927","article-title":"Bcl11b is required for differentiation and survival of alphabeta T lymphocytes","volume":"4","author":"Wakabayashi","year":"2003","journal-title":"Nat Immunol"},{"issue":"5987","key":"10.1016\/j.humpath.2026.106057_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1188995","article-title":"An essential developmental checkpoint for production of the T cell lineage","volume":"329","author":"Ikawa","year":"2010","journal-title":"Science"},{"issue":"5987","key":"10.1016\/j.humpath.2026.106057_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.1188989","article-title":"An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.humpath.2026.106057_bib4","first-page":"773","article-title":"14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia","volume":"138","author":"Di Giacomo","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.humpath.2026.106057_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/bjh.19363","article-title":"T\/myeloid mixed phenotype acute leukaemia harbouring TLX3::BCL11B with TLX3 activation","volume":"205","author":"Botten","year":"2024","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.humpath.2026.106057_bib6","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/bjh.17681","article-title":"B-cell lymphoma\/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia\/lymphoma (ETP-ALL\/LBL) from other subtypes of T-cell ALL\/LBL","volume":"194","author":"Fang","year":"2021","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.humpath.2026.106057_bib7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.pathol.2022.04.012","article-title":"Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms","volume":"54","author":"Fang","year":"2022","journal-title":"Pathology"},{"issue":"11","key":"10.1016\/j.humpath.2026.106057_bib8","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.humpath.2026.106057_bib9","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.humpath.2026.106057_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","article-title":"International consensus classification of acute lymphoblastic leukemia\/lymphoma","volume":"482","author":"Duffield","year":"2023","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.humpath.2026.106057_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2021.101329","article-title":"Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage","volume":"34","author":"Montefiori","year":"2021","journal-title":"Best Pract Res Clin Haematol"},{"issue":"11","key":"10.1016\/j.humpath.2026.106057_bib12","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1158\/2159-8290.CD-21-0145","article-title":"Enhancer hijacking drives oncogenic BCL11B expression in lineage-ambiguous stem cell leukemia","volume":"11","author":"Montefiori","year":"2021","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.humpath.2026.106057_bib13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/pbc.22850","article-title":"Successful treatment of a child with T\/myeloid acute bilineal leukemia associated with TLX3\/BCL11B fusion and 9q deletion","volume":"56","author":"Oliveira","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.humpath.2026.106057_bib14","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1158\/0008-5472.CAN-06-2615","article-title":"Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1","volume":"67","author":"Nagel","year":"2007","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.humpath.2026.106057_bib15","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1182\/blood-2006-07-032953","article-title":"HOX11L2\/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32)","volume":"108","author":"Su","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.humpath.2026.106057_bib16","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1038\/s41375-020-0761-9","article-title":"T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T\/myeloid","volume":"34","author":"Wang","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106057_bib17","series-title":"Hematolymphoid tumors 5th ed. Myelodysplastic neoplasms","author":"Board","year":"2024"},{"key":"10.1016\/j.humpath.2026.106057_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100862","article-title":"Optical genome mapping in myelodysplastic syndromes: clinical value and limitations derived from a cohort of 236 patients","author":"Wei","year":"2025","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106057_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.27575","article-title":"Chromoanagenesis is frequently associated with highly complex karyotypes, extensive clonal heterogeneity, and treatment refractoriness in acute myeloid leukemia","author":"Wei","year":"2025","journal-title":"Am J Hematol"},{"issue":"24","key":"10.1016\/j.humpath.2026.106057_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16244193","article-title":"Detection of KMT2A partial tandem duplication by optical genome mapping in myeloid neoplasms: associated cytogenetics, gene mutations, treatment responses, and patient outcomes","volume":"16","author":"Wei","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.humpath.2026.106057_bib21","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/ajh.27435","article-title":"Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia","volume":"99","author":"Loghavi","year":"2024","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106057_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41408-024-01059-x","article-title":"A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping","volume":"14","author":"Zou","year":"2024","journal-title":"Blood Cancer J"},{"issue":"9","key":"10.1016\/j.humpath.2026.106057_bib23","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/s41436-019-0545-7","volume":"21","author":"Mikhail","year":"2019","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.humpath.2026.106057_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17091436","article-title":"Clinical utility of optical genome mapping as an additional tool in a standard cytogenetic workup in hematological malignancies","volume":"17","author":"Toruner","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.humpath.2026.106057_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ajh.27575","article-title":"Chromoanagenesis is frequently associated with highly complex karyotypes, extensive clonal heterogeneity, and treatment refractoriness in acute myeloid leukemia","volume":"100","author":"Wei","year":"2025","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.humpath.2026.106057_bib26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.pathol.2025.01.007","article-title":"Acute lymphoblastic leukaemia with T- and B-lineage defining markers","volume":"57","author":"E","year":"2025","journal-title":"Pathology"},{"issue":"6","key":"10.1016\/j.humpath.2026.106057_bib27","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.pathol.2025.01.010","article-title":"BCL11B helps to define T-lineage in lymphomas\/leukaemias with a mixed\/ambiguous immunophenotype","volume":"57","author":"E","year":"2025","journal-title":"Pathology"},{"issue":"11","key":"10.1016\/j.humpath.2026.106057_bib28","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.3324\/haematol.2022.282605","article-title":"The oncogenetic landscape and clinical impact of BCL11B alterations in adult and pediatric T-cell acute lymphoblastic leukemia","volume":"108","author":"Dourthe","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2026.106057_bib29","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2025028985","article-title":"Venetoclax plus gilteritinib is effective in preclinical models of FLT3-mutant BCL11B-a lineage-ambiguous leukemia","author":"Montefiori","year":"2025","journal-title":"Blood"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T05:11:07Z","timestamp":1776575467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"alternative-id":["S0046817726000262"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106057","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute leukemia with BCL11B rearrangements: Genetic landscape, BCL11B expression, and therapeutic response","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106057"}}